Endometrial Hyperplasia
What Are The Symptoms of
Endometrial Hyperplasia
- Abnormal vaginal bleeding between menstrual periods or post-menopause
- Abnormally heavy menstrual bleeding or the absence of a menstrual period (amenorrhea)
- Painful intercourse
- Menstrual cycles wherein ovulation does not occur (anovulatory periods)
When to See a Doctor
How Advanced Gynecology Can Help
What Are the Causes & Treatments for Bacterial Vaginosis?
Causes of Endometrial Hyperplasia?
Postmenopausal women are at risk for endometrial hyperplasia when undergoing unopposed estrogen replacement therapy. In this type of therapy, progesterone is not administered. Women receiving this type of hormone treatment tend to experience a higher incidence of endometrial hyperplasia.
During a normal menstrual cycle, estrogen causes the endometrium to thicken, preparing the uterus for pregnancy. Then, during ovulation, the ovary releases an egg. Finally, after ovulation, progesterone increases to prepare the endometrium to receive a fertilized egg. When pregnancy does not occur, levels of both estrogen and progesterone decrease and menstruation begins, which sheds the lining of the endometrium.
The endometrial lining fails to shed when there is an absence of progesterone. In these cases, there is a hormonal imbalance where there is too much estrogen and not enough progesterone.
Treatment of Endometrial Hyperplasia
To accurately diagnose endometrial hyperplasia, a tissue biopsy provides the most conclusive answers. This can be done by endometrial biopsy, dilation and curettage (D&C), or hysteroscopy. A preliminary screening may include a transvaginal ultrasound which can measure the thickness of the endometrium. D&C may also help to treat hyperplasia by removing some of the excess endometrial tissue.
One available treatment for endometrial hyperplasia is progestin, which is available as an oral medication, vaginal cream, intravenously or as an intrauterine device.
Hysterectomy may be recommended in some cases where hyperplasia is treatment-resistant or in cases of recurring endometrial hyperplasia after successful treatment or the development of atypical (premalignant) endometrial hyperplasia.